SEC 13F Intelligence

Deep Track Capital, LP / AKRO

Deep Track Capital, LP’s Akero Therapeutics Inc Com Position

Does Deep Track Capital, LP own Akero Therapeutics Inc Com (AKRO)? Not currently — the last reported position was 4.00M shares worth $190M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$190M
Q3 2025
Shares
4.00M
% of Portfolio
+5.30%
Quarters Held
6
position exited

Position History AKRO

Reported value by quarter
Q3 ’22: $27MQ3 ’22Q3 ’24: $20MQ3 ’24Q4 ’24: $41MQ4 ’24Q1 ’25: $130MQ1 ’25Q2 ’25: $162MQ2 ’25Q3 ’25: $190MQ3 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20254.00M$190M+5.30%
Q2 20253.04M$162M+5.21%
Q1 20253.21M$130M+4.21%
Q4 20241.49M$41M+1.55%
Q3 2024689.8K$20M+0.63%
Q3 2022790.9K$27M+1.23%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Deep Track Capital, LP’s full portfolio or all institutional holders of AKRO.